close
close
April 27, 2021
Bantam Pharmaceutical Appoints Industry Veteran

Bantam Pharmaceutical Appoints Industry Veteran Michael Stocum as President and Chief Executive Officer New York, N.Y. - April 27, 2021 —Bantam Pharmaceutical, a drug discovery, and development company targeting selective modulation of mitochondrial dynamics in cancer, announced today that it has named Michael Stocum, MS as President and Chief Executive Officer. Mr. Stocum succeeds the […]

Read More
August 2, 2020
Bantam Presents at the AACR Virtual Meeting: Advances in Malignant Lymphoma - August 2020
Read More
July 6, 2018
Bantam Presents at the Inaugural AACR Advances in Malignant Lymphoma Meeting - June 2018
Read More
July 6, 2017
Bantam Publication in Bioorganic & Medicinal Chemistry Letters - June 2017
Read More
1 2
We are an early mover in the field of mitochondrial homeostasis, using our pioneering science and unrivaled expertise in mitochondrial cellular biology to revolutionize oncology
We are seeking partners and additional investors to accelerate our clinical research and help bring novel cancer therapies closer to patients in need
Find Out More
Bantam is seeking partners and investors to drive rapid clinical development of our first-in-class molecule from First in Humans trials to clinical Proof of Concept.
Menu
close
CONTACT US
Terms & Conditions
Privacy Policy
(646) 598-4823
info@bantampharma.com
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram